Clinical Trial Update: Evaluation of the Safety and Efficacy of HK-660S in Patients With Primary Sclerosing Cholangitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of HK-660S in patients with primary sclerosing cholangitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis

Drugs mentioned

• HK-660S

Snippet

Sponsor: CuromeBiosciences | Conditions: Primary Sclerosing Cholangitis | Phase 2 | Status: COMPLETED